Fusayuki Omori

553 total citations
36 papers, 458 citations indexed

About

Fusayuki Omori is a scholar working on Immunology, Oncology and Genetics. According to data from OpenAlex, Fusayuki Omori has authored 36 papers receiving a total of 458 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Immunology, 10 papers in Oncology and 10 papers in Genetics. Recurrent topics in Fusayuki Omori's work include Immune Response and Inflammation (7 papers), Virus-based gene therapy research (4 papers) and Blood disorders and treatments (4 papers). Fusayuki Omori is often cited by papers focused on Immune Response and Inflammation (7 papers), Virus-based gene therapy research (4 papers) and Blood disorders and treatments (4 papers). Fusayuki Omori collaborates with scholars based in Japan, Canada and United States. Fusayuki Omori's co-authors include Yoshiyuki Niho, Kazuya Shimoda, Seiichi Okamura, S Okamura, Y Niho, Shin Hayashi, Tetsuya Matsuguchi, Kowichi Jimbow, Takeshi Otsuka and Mine Harada and has published in prestigious journals such as Blood, Journal of Investigative Dermatology and Journal of the American Academy of Dermatology.

In The Last Decade

Fusayuki Omori

34 papers receiving 446 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fusayuki Omori Japan 13 177 114 106 91 81 36 458
R.J. Hartzman United States 11 406 2.3× 61 0.5× 123 1.2× 80 0.9× 71 0.9× 21 658
D Buriot France 9 152 0.9× 97 0.9× 294 2.8× 91 1.0× 111 1.4× 28 571
H. Makni Tunisia 14 269 1.5× 57 0.5× 82 0.8× 118 1.3× 59 0.7× 51 692
Takafumi Okuno Japan 11 257 1.5× 143 1.3× 97 0.9× 124 1.4× 25 0.3× 12 562
G. P. Sandilands United Kingdom 13 383 2.2× 187 1.6× 195 1.8× 122 1.3× 64 0.8× 40 809
Bénédicte Mugnier France 10 251 1.4× 153 1.3× 79 0.7× 34 0.4× 92 1.1× 28 708
Todd A. Braciak Germany 16 274 1.5× 196 1.7× 154 1.5× 74 0.8× 37 0.5× 32 625
T J Lawley United States 7 197 1.1× 79 0.7× 154 1.5× 20 0.2× 45 0.6× 11 490
R Martucci Italy 10 263 1.5× 224 2.0× 149 1.4× 43 0.5× 141 1.7× 12 678
J Wasserman Sweden 16 211 1.2× 150 1.3× 54 0.5× 38 0.4× 26 0.3× 38 477

Countries citing papers authored by Fusayuki Omori

Since Specialization
Citations

This map shows the geographic impact of Fusayuki Omori's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fusayuki Omori with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fusayuki Omori more than expected).

Fields of papers citing papers by Fusayuki Omori

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fusayuki Omori. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fusayuki Omori. The network helps show where Fusayuki Omori may publish in the future.

Co-authorship network of co-authors of Fusayuki Omori

This figure shows the co-authorship network connecting the top 25 collaborators of Fusayuki Omori. A scholar is included among the top collaborators of Fusayuki Omori based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fusayuki Omori. Fusayuki Omori is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Saga, Kenji, et al.. (2004). The chilblain-like eruption as a diagnostic clue to the blast crisis of chronic myelocytic leukemia. Journal of the American Academy of Dermatology. 50(2). 42–44. 17 indexed citations
2.
Saga, Kenji, et al.. (2003). Pyoderma Chronica Occurring on Both Lower Legs. The Nishinihon Journal of Dermatology. 65(6). 589–591.
3.
Jin, Hai‐Ying, et al.. (2003). Detection of tyrosinase and tyrosinase-related protein 1 sequences from peripheral blood of melanoma patients using reverse transcription-polymerase chain reaction. Journal of Dermatological Science. 33(3). 169–176. 12 indexed citations
4.
Omori, Fusayuki, Tarja Juopperi, Yung‐Nien Chang, et al.. (1999). Retroviral-Mediated Transfer and Expression of the Multidrug Resistance Protein 1 Gene (MRP1) Protect Human Hematopoietic Cells from Antineoplastic Drugs. Journal of Hematotherapy & Stem Cell Research. 8(5). 503–514. 7 indexed citations
5.
Lutzko, Carolyn, Fusayuki Omori, Anthony C. G. Abrams‐Ogg, et al.. (1999). Gene Therapy for Canine alpha-L-Iduronidase Deficiency: In Utero Adoptive Transfer of Genetically Corrected Hematopoietic Progenitors Results in Engraftment but Not Amelioration of Disease. Human Gene Therapy. 10(9). 1521–1532. 43 indexed citations
6.
Teshima, Takanori, Masahiro Murakawa, Y Niho, et al.. (1993). A randomized phase II trial of low-dose aclarubicin vs very low-dose cytosine arabinoside for treatment of myelodysplastic syndromes. Leukemia Research. 17(8). 629–632. 6 indexed citations
7.
Kubota, Akira, et al.. (1992). A traditional chinese herbal medicine, juzen-taiho-to augments the production of granulocyte/macrophage colony-stimulating factor from human peripheral blood mononuclear cells in vitro. 8(4). 191–195. 18 indexed citations
8.
Omori, Fusayuki, Seiichi Okamura, Kazuya Shimoda, et al.. (1992). Levels of human serum granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor under pathological conditions. Biotherapy. 4(2). 147–153. 39 indexed citations
9.
Shimoda, Kazuya, S Okamura, Naoki Harada, Fusayuki Omori, & Yoshiyuki Niho. (1992). Serum granulocyte colony-stimulating factor levels in umbilical cord blood of normal full-term neonates. Biomedicine & Pharmacotherapy. 46(8). 337–341. 4 indexed citations
10.
Kondo, Seiji, Seiichi Okamura, Naoki Harada, et al.. (1992). CD7-positive acute myeloid leukemia: further evidence of cellular immaturity. Journal of Cancer Research and Clinical Oncology. 118(5). 386–388. 7 indexed citations
11.
12.
Okamura, Seiichi, Takeshi Tanaka, Shigeru Yamaga, Fusayuki Omori, & Yoshiyuki Niho. (1991). The effects of recombinant human granulocyte-macrophage colony-stimulating factor on the induction of lymphokine-activated killer cells in vitro. International Journal of Immunopharmacology. 13(5). 587–593. 6 indexed citations
13.
Dohmen, Kazufumi, et al.. (1991). IgG-kappa type multiple myeloma in alcoholic cirrhosis--a case report.. PubMed. 82(6). 391–7. 2 indexed citations
14.
Shimoda, Kazuya, Seiichi Okamura, Fusayuki Omori, et al.. (1991). Detection of Granulocyte-Macrophage Colony-Stimulating Factor in Cerebrospinal Fluid of Patients with Aseptic Meningitis. Acta Haematologica. 86(1). 36–39. 13 indexed citations
15.
Shimoda, Kazuya, et al.. (1990). Production of interleukin-6 from macrophages by MDP-Lys (L 18), romurtide.. PubMed. 70(3). 289–96. 11 indexed citations
16.
Kawasaki, Chika, S Okamura, Fusayuki Omori, et al.. (1990). Both granulocyte-macrophage colony-stimulating factor and monocytic colony-stimulating factor are produced by the human T-cell line, HUT 102.. PubMed. 18(10). 1090–3. 10 indexed citations
17.
Shimoda, Kazuya, et al.. (1990). Muroctasin [MDP-Lys(18)] augments the production of granulocyte colony-stimulating factor (G-CSF) from human peripheral blood mononuclear cells in vitro. International Journal of Immunopharmacology. 12(7). 729–736. 15 indexed citations
18.
19.
Omori, Fusayuki, S Okamura, Fumimaro Takaku, & Yoshiyuki Niho. (1989). Measurement of human G-CSF by enzyme-linked immunosorbent assay using monoclonal antibody. Research in Experimental Medicine. 189(3). 163–171. 21 indexed citations
20.
Omori, Fusayuki, et al.. (1989). Measurement of human granulocyte-macrophage colony-stimulating factor (GM-CSF) by enzyme-linked immunosorbent assay. Biotherapy. 1(3). 161–167. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by R.J. Hartzman Breakdown of academic impact, for papers by D Buriot Breakdown of academic impact, for papers by H. Makni Breakdown of academic impact, for papers by Takafumi Okuno Breakdown of academic impact, for papers by G. P. Sandilands Breakdown of academic impact, for papers by Bénédicte Mugnier Breakdown of academic impact, for papers by Todd A. Braciak Breakdown of academic impact, for papers by T J Lawley Breakdown of academic impact, for papers by R Martucci Breakdown of academic impact, for papers by J Wasserman
Rankless by CCL
2026